On May 8, 2026, The Timken Company (the Company ) entered into a letter agreement (the Letter Agreement ) with Hansal N. Patel, the Company s Executive Vice President, General Counsel and Corporate Development.

(e) On May 4, 2026, Vaso Corporation ( Vaso ) entered into an agreement with Peter Castle, President of VasoTechnology Inc., a wholly-owned subsidiary of Vaso. The agreement provides an opportunity to earn an incentive payment for Mr.

Dr. Elizabeth Stoner appointed as Class II director. effective May 7, 2026.

Randall Keys will not stand for re-election. effective May 8, 2026.

Suzanne Nora Johnson appointed as director. effective July 13, 2026.

Collier has been promoted to the Company s Chief Operating Officer and Executive Vice President from his prior role as the Company s EVP, Corporate Strategy, Development Operations. Collier will lead enterprise operations across HealthStream, including customer experience functions, corporate development and mergers and acquisitions, implementations, legal, human resources, partnerships, business enablement, and other critical areas.

Christopher S. Fraser appointed as director.

Fisher, Senior Vice President Product Supply, Trading and Wholesale of Valero Energy Corporation ( Valero ), informed Valero that he intends to retire on or about July 1, 2026. Fisher plans to help transition his responsibilities internally as part of Valero s succession plan.

Grant Thornton replaced as auditor. Grant Thornton appointed as new auditor.

✦Grant Thornton out, Grant Thornton in — national to national swap — monitor for any disclosed disagreements.

Mr. Jeffrey Gennette appointed as director. Mr. Gennette appointed as director. Nancy Reardon will not stand for re-election. Mr. Jeffrey Gennette will not stand for re-election.

✦Jeffrey Gennette joins Signet Jewelers' board as director while Nancy Reardon departs, signaling potential strategic shifts in the jewelry retailer's governance and leadership direction.

👤 Mr. Jeffrey Gennette — Jeffrey Gennette, age 65, served as Chief Executive Officer of Macy's, Inc. from March 2017 to February 2024 and as Chairman from February 2018 to April 2024, following a more than 40-year career at Macy's in roles of increasing responsibility including President, Chief Merchandising Officer, and multiple regional chairman and CEO positions. He currently serves on the board of advisors for Edward Jones Investments and the board of directors for the National AIDS Memorial.

Corporation since 1975, did not stand for re-election and retired from our Board of Directors effective May 6, 2026.

✦F.N.B. Corporation experienced a board transition as a long-tenured director retired, which may signal potential strategic or governance shifts ahead for the regional financial institution.

Acceleration of Vesting Having reached the applicable retirement age under WEC Energy Group s Corporate Governance Guidelines, Gale Klappa completed his service as Chairman of the Board on May 7, 2026. Klappa s years of service and contributions to the success of WEC Energy Group, the Compensation Committee approved the acceleration of the vesting of unvested shares of restricted stock awarded to Mr.

✦WEC Energy Group's former Chairman Gale Klappa received accelerated vesting of restricted stock upon his May 2026 retirement, recognizing his long tenure and contributions to the utility company.

ortfolio of net assets of the Terra Funds to us in exchange for all of the shares of common stock of the Company. BDC Merger On October 1, 2022 (the BDC Merger Closing Date ), pursuant to the Merger Agreement, dated October 1, 2022 (the Merger Agreement ), by and between Terra Income Fund 6, Inc.

✦Terra Property Trust (TPTA) merged with Terra Income Fund 6 in October 2022, with TPTA shareholders receiving the combined entity's net assets in exchange for their common stock.

ding arising by reason of the Indemnitee s service as a director or officer of the Company or, at the Company s request, in similar capacities at other entities, and will advance such expenses within 30 days following receipt of a written request (subject to a limited extension in certain circumstances), with repayment required only if it is ultimately determined by a final, non-appealable judicial decision that the Indemnitee is not entitled to indemnification. The Company s obligations under t

✦Nakamoto Inc. expanded executive indemnification protections, committing to advance legal expenses for directors and officers within 30 days, potentially increasing shareholder liability exposure.

On May 5, 2026, the Board of Directors of Amtech Systems, Inc. Guy Shechter as the Company s President and Chief Operating Officer, effective May 19, 2026, reporting to the Chief Executive Officer of the Company.

✦Amtech Systems appointed Guy Shechter as President and Chief Operating Officer effective May 19, 2026, expanding leadership to support operational oversight under the existing CEO.

Rassieur, III retired from the Board of Directors of Commerce Bancshares, Inc. ( Company ) effective May 7th, 2026, due to the mandatory retirement requirements of the Company.

✦Commerce Bancshares' board member Rassieur III retired due to mandatory age requirements, representing routine governance changes with minimal direct investor impact.

Entered into Agreement and Plan of Merger.

✦Cross Country Healthcare agreed to merge, creating potential shareholder value through a strategic combination that will be determined by the final transaction terms and regulatory approval.

David Moradi appointed as director. Ms. Georgevich appointed as director. Kelly Georgevich appointed as Chief Financial Officer.

✦AudioEye (AEYE) appointed Kelly Georgevich as Chief Financial Officer and added her and David Moradi as directors, strengthening leadership amid potential operational transitions.

👤 David Moradi — Kelly Georgevich, age 43, has over 15 years of experience in high-growth software-as-a-service and technology companies, having served as AudioEye's Chief Financial Officer since June 2021. Prior to AudioEye, she was chief financial officer of sticky.io, Inc. (an e-commerce platform) from September 2018 onward and vice president of finance there from March 2015, and previously served as controller at Fuzebox Software Corporation where she supported a successful acquisition. She also served on the Board of Directors for Girls in Tech as secretary and treasurer from 2015 to 2020.

The preceding description of the Agreements is a summary only and is qualified in its entirety by the text of the Agreements, copies of which are attached hereto as Exhibit 10.1 (Mr.

✦Luxfer Holdings appointed new executive leadership under formal agreements, with complete terms detailed in filed exhibits, potentially signaling strategic direction changes for the industrial gas cylinder manufacturer.

Paul Hohnsbeen appointed as independent director.

✦Target Hospitality appointed Paul Hohnsbeen as an independent director, strengthening its board governance structure.

👤 Paul Hohnsbeen — Paul Hohnsbeen is a senior digital infrastructure and real estate executive with over three decades of experience in capital-intensive environments. Since 2022, he has served as Chief Operations Officer of Aligned Data Centers, and previously held leadership roles including Vice President of IBX Operations Europe, Middle East and Africa at Equinix (2016-2021), Group Chief Operating Officer at Global Switch (2010-2012), and various executive positions at Lehman Brothers focused on private equity real estate and corporate real estate (2002-2008). He also held senior roles at Deutsche Bank, Morgan Stanley, and architectural firms, and holds a Bachelor of Arts in Architecture from UC Berkeley.

Evangelos Perros resigned as Chief Executive Officer. Jonathan Dobres resigned as director. Jonathan Do resigned as director. effective June 15, 2026.

✦Pagaya Technologies faces executive leadership transition with CEO Evangelos Perros and two directors departing June 15, 2026, creating uncertainty about strategic direction and governance.

related to the Cooperation Agreement (as defined below) is incorporated by reference herein.

✦Viasat's executive change relates to its Cooperation Agreement, though specific personnel details and implications for leadership or strategy remain unclear from this summary.

Michael R. Kenison appointed as Chief Commercial Officer. Bernardo Parlange appointed as Chief Commercial Officer. effective July 1, 2026.

✦Proto Labs appointed Michael R. Kenison and Bernardo Parlange as Chief Commercial Officers effective July 1, 2026, signaling leadership restructuring in sales and business development roles.

👤 Michael R. Kenison — I should note that the search results show Michael R. Kenison is currently the Chief Operations Officer (COO) at Proto Labs, not Chief Commercial Officer as mentioned in your question. Based on the available information: Michael R. Kenison served as Vice President of Manufacturing at Proto Labs from 2013–2021, led the Americas business from 2021–2024, and has been Chief Operations Officer since July 2024. Prior to Proto Labs, he held the role of VP of Manufacturing at Cardiac Science, a medical device provider specializing in defibrillator technology.

Steven A. Michaels appointed as director. Lead Independent Director appointed as Director.

✦PROG Holdings appointed Steven A. Michaels as director and established a Lead Independent Director position, strengthening board governance and oversight structure.

👤 Steven A. Michaels — Steven A. Michaels has served as the Company's President and Chief Executive Officer, a position from which he has built an outstanding management team, delivered strong financial performance, and made strategic investments to grow the Company's ecosystem of payment solutions and diversify its product portfolio. On May 7, 2026, he was elected to the additional position of Chairman of the Board effective immediately.

below, on May 5, 2026, VSE completed the PAG Acquisition (the Closing ).

✦VSE Corporation completed its acquisition of PAG on May 5, 2026, expanding its portfolio and potentially enhancing operational capabilities and revenue streams.

Emmanuel Caprais resigned as director. effective May 8, 2026.

✦Emmanuel Caprais resigned from ITT Inc.'s board of directors effective May 8, 2026, reducing board size and potentially signaling leadership transitions at the industrial manufacturing company.

Michelle Hook appointed as Chief Financial Officer.

✦Shake Shack appointed Michelle Hook as CFO, signaling a leadership transition that investors should monitor for potential strategic shifts in financial management and operational priorities.

👤 Michelle Hook — Michelle Hook, age 51, was appointed Chief Financial Officer of Shake Shack effective May 11, 2026. She previously served as CFO of Portillo's Inc. since December 2020, where she led finance, supply chain, and information technology functions and supported the company's 2021 IPO, and prior to that spent over 17 years at Domino's Pizza in various finance and accounting roles, including Vice President of Finance for global FP&A and investor relations. Her career also includes positions at Holcim and Arthur Andersen LLP, and she holds an MBA from the University of Michigan, a B.A. in accounting from Michigan State University, and is a certified public accountant.

Adam L. Metz appointed as President. Senior Executive Vice President appointed as Executive Vice President.

✦Orrstown Financial Services promoted Adam L. Metz to President while elevating a Senior Executive Vice President to Executive Vice President, signaling internal leadership restructuring.

👤 Adam L. Metz — Adam L. Metz, age 54, joined Orrstown Financial Services in 2016 and has progressed through several senior leadership roles, including Executive Vice President and Chief Lending Officer (2016-2019), Executive Vice President and Chief Revenue Officer (2019-2025), and Senior Executive Vice President and Chief Operating Officer (2025-2026). Prior to joining Orrstown, he served as Senior Vice President and Chief Lending Officer at Metro Bank in Harrisburg, Pennsylvania from 2011 to 2016.

Anthony K. McDonald resigned as President.

✦Anthony K. McDonald's resignation as President of CEA Industries Inc. (BNC) creates leadership uncertainty and may impact near-term operational continuity and investor confidence.

Shure will continue in his roles to ensure continuity and an orderly transition. The decision to part ways was not the result of any disagreement between Mr.

✦The Children's Place's executive transition maintains continuity during leadership change, with the departing executive remaining involved to ensure an orderly handoff without any underlying disputes.

Peter Doyle appointed as director.

✦Texas Pacific Land Corporation appointed Peter Doyle as a director, strengthening its board with new leadership that may influence future strategic decisions and governance direction.

👤 Peter Doyle — Peter Doyle is a co-founder and Co-Chief Executive Officer of Horizon Kinetics (OTCQX: HKHC), where he serves as a senior research team member and investment committee member, and also serves as President of Kinetics Mutual Funds, Inc. and Co-Portfolio Manager for multiple registered investment companies and funds. Previously, he was a Senior Investment Officer at Bankers Trust Company (1985-1994), where he served on Finance, Utility, and REIT Research teams, and he currently serves as Chairman and Co-Chief Executive Officer of FRMO Corp. (OTCID: FRMO).

Terrie Kellmeyer appointed as Interim Chief Executive Officer. Christopher Missling resigned as Interim Chief Executive Officer. Terrie Kellmeyer resigned as Interim Chief Executive Officer.

✦Anavex Life Sciences named Terrie Kellmeyer interim CEO following Christopher Missling's resignation, though Kellmeyer simultaneously resigned from the same position, creating leadership uncertainty.

👤 Terrie Kellmeyer — Dr. Terrie Kellmeyer possesses over 30 years of pharmaceutical industry experience with executive leadership roles spanning Clinical Development, Regulatory Affairs, Clinical Operations, and Medical Affairs across multiple therapeutic areas. Her prior positions include Group Vice President of Clinical Development at Acer Therapeutics, Head of Global Regulatory Affairs at Madrigal Pharmaceuticals, and roles of increasing responsibility at Intercept Pharmaceuticals, Amylin Pharmaceuticals, and Gen-Probe, along with consulting work for Tunnell Consulting and i2o Therapeutics. She holds a BS in Biotechnology from Rochester Institute of Technology, a PhD in Cell and Molecular Biology from SUNY Syracuse, and completed a Post-Doctoral Fellowship at the University of Rochester.

Acquisition for $346,954,197.

✦Nuveen Churchill Private Capital Income Fund (BNS) completed an acquisition valued at approximately $347 million, expanding its investment portfolio and potentially enhancing shareholder returns through increased asset base and diversification.

Acquisition for $346,954,197.

✦Nuveen Churchill BDC V (BNS) completed a $347 million acquisition, expanding its investment portfolio and potentially enhancing shareholder returns through increased asset base and diversification.

Peter W. Wilson appointed as director. Mr. Wilson appointed as director.

✦Hamilton Insurance Group appointed Peter W. Wilson as a director, potentially strengthening board oversight and governance as the company navigates its insurance operations.

👤 Peter W. Wilson — Peter W. Wilson is an accomplished insurance executive with more than three decades of leadership experience across global specialty, commercial and professional liability markets. Most recently, he served as Chief Executive Officer of AXIS Insurance, and previously held senior leadership roles at CNA Insurance Companies, including President and Chief Operating Officer of CNA Specialty, after beginning his career at AIG. He has served on multiple insurance and reinsurance boards, including AXIS Specialty, CNA Europe and QBE Insurance Group, and is a former President of the Professional Liability Underwriting Society (PLUS) and the PLUS Foundation.

The Johnson resigned as director. effective April 1, 2026.

✦Bimergen Energy Corporation (BESS) loses director Johnson effective April 1, 2026, creating a potential board vacancy that could signal internal changes or shift governance dynamics.

On May 5, 2026 (the Effective Date ), the Compensation Committee (the Committee ) of the Board of Directors of Once Upon a Farm, PBC, a Delaware public benefit corporation (the Company ), approved a revised compensation package for Lawrence Waldman, the Company s President and Chief Financial Officer. Waldman s base salary will be increased to $450,000 per year, effective May 5, 2026; provided, that such compensation shall be annually reviewed by the Committee, (ii) Mr.

✦Once Upon a Farm (OFRM) increased President and CFO Lawrence Waldman's base salary to $450,000 annually, effective May 5, 2026, with annual committee reviews.

Stephanie S. Hoppe appointed as director. Lawrence A. Barbetta will not stand for re-election. effective May 5, 2026.

✦Winmark Corporation appointed Stephanie S. Hoppe as director while Lawrence A. Barbetta departed the board, effective May 5, 2026, representing modest leadership transition.

👤 Stephanie S. Hoppe — Stephanie S. Hoppe currently serves as vice president of omnichannel marketing at Casey's General Stores, Inc. , and has deep experience in omnichannel, data-driven marketing and franchise and multi-unit retail from roles at Casey's General Stores, Cicis Pizza and 7-Eleven . She was appointed as a director of Winmark Corporation effective May 5, 2026 , where her background in consumer engagement, data-driven marketing, omnichannel growth, and customer loyalty, along with her proven track record of enabling data-driven consumer marketing strategies across both franchise and multi-unit retail environments , are expected to strengthen the company.

Entered into agreement and plan of merger with Polar Merger Sub, LLC. $40 million.

✦Core Scientific agreed to be acquired by Polar Merger Sub in a transaction valued at $40 million, significantly diluting existing shareholders' equity value.

Martin H. Huber appointed as Class III director. Martin H. Huber resigned as director.

✦Martin H. Huber's simultaneous appointment and resignation as a Class III director at Actuate Therapeutics suggests a routine board reclassification or procedural change rather than material leadership disruption for ACTU shareholders.

👤 Martin H. Huber — Dr. Martin H. Huber brings extensive biopharmaceutical executive experience, having served as President and CEO of Mersana Therapeutics from 2023 to January 2026 (and director since 2020) until its acquisition by Day One Biopharmaceuticals, and prior roles including President of R&D at Xilio Therapeutics and Chief Medical Officer at TESARO, Inc. before its 2019 acquisition by GlaxoSmithKline. His career also includes senior positions at Merck Research Laboratories, Schering-Plough, Hoffmann-La Roche, and Rhone-Poulenc Rorer, with particular expertise in oncology clinical development and drug safety, along with prior academic experience as Assistant Professor of Oncology at the University of Texas M.D. Anderson Cancer Center. He holds an M.D. from Baylor College of Medicine and currently serves on the board of Syndax Pharmaceuticals as chair of the Science and Technology Committee.

(the Company or Wiley ) issued a press release today, May 6, 2026, announcing the departure of Jay Flynn, Executive Vice President and General Manager, Research and Learning, and the appointment of Jessica Kowalski, Executive Vice President and General Manager, Research, effective May 11, 2026. Kowalski, joins Wiley from Microsoft, bringing more than two decades of experience leading knowledge, data, research publishing, and AI-enabled businesses at global scale, including senior operating roles

✦Wiley replaces departing Executive Vice President Jay Flynn with Jessica Kowalski from Microsoft, bringing two decades of experience in research publishing and AI-enabled businesses to lead the Research segment.

Michael R. Cannon will not stand for re-election.

✦Seagate Technology's board member Michael R. Cannon is departing, reducing board size and potentially signaling strategic shifts in leadership composition at the storage technology company.

Mr. Petras appointed as Executive Chairman.

✦Sotera Health Company's appointment of Mr. Petras as Executive Chairman signals potential strategic shifts in leadership and governance, which investors should monitor for implications on company direction and performance.

👤 Mr. Petras — Alton Shader, age 52, brings more than 20 years of experience in global medical device leadership, having served as Chief Executive Officer and board member of Viant Medical, LLC since 2019. Prior to Viant, he held several senior leadership positions at Hill-Rom, including President of its global Front Line Care business, and previously served in senior roles at Baxter International Inc., including General Manager of its North America Renal business. Mr. Shader holds a bachelor's degree in economics and psychology from Claremont McKenna College and an M.B.A. from Stanford University.

On May 4, 2026 (the Grant Date ), the Compensation Committee of the Board of Directors (the Board ) of FibroBiologics, Inc. Davis, the Company s Chief Financial Officer, Hamid Khoja, Ph.D., the Company s Chief Scientific Officer, and Ruben A.

✦FibroBiologics granted equity awards to its CFO and Chief Scientific Officer, signaling management retention efforts amid ongoing operations in the regenerative medicine sector.

Anthony Carroll appointed as President. Anthony Carroll resigned as Chief Executive Officer.

✦FTC Solar appointed Anthony Carroll as President while he stepped down as CEO, signaling potential leadership restructuring that investors should monitor for strategic direction changes.

👤 Anthony Carroll — Anthony Carroll, age 42, brings extensive experience in energy storage and sustainable building technologies. He previously served as Chief Executive Officer of Veev (a Lennar subsidiary focused on efficient homebuilding) until April 2026, and before that held the position of President at Powin, a global energy storage systems company. Prior to joining Powin in 2022, Mr. Carroll served as Managing Director at Siemens Gamesa Electric leading the Power Conversion and Energy Storage business in North America, and held leadership roles at Schneider Electric and Power Electronics.

Larry Kellerman appointed as Class III director. Melissa A. Neugebauer appointed as Class III director.

✦Fermi Inc. appointed Larry Kellerman and Melissa A. Neugebauer as Class III directors, expanding board oversight and potentially signaling new strategic direction or governance changes.

👤 Larry Kellerman — Larry Kellerman brings more than four decades of power industry and finance expertise, with his career spanning senior leadership positions at Goldman Sachs, El Paso Corporation, and I Squared Capital. He is credited as architect of Fermi's 17-gigawatt Amarillo energy campus, having led design and power strategy for the company's large private energy grid. Kellerman is co-founder and Managing Partner of Twenty First Century Utilities.

Dr. Stuart Essig appointed as officer.

✦Integra LifeSciences (IART) appointed Dr. Stuart Essig as an officer, signaling potential organizational restructuring that could affect operational leadership and strategic direction.

👤 Dr. Stuart Essig — Dr. Stuart M. Essig previously served as Integra LifeSciences' Chief Executive Officer and President from 1997 to 2012, then as Chairman of the Board since January 2012 and Executive Chairman from February 2024 to June 2025. Before joining Integra, he was a managing director in mergers and acquisitions for the medical technology practice at Goldman Sachs, and he cofounded Prettybrook Partners, LLC in 2012, a family office investing in healthcare companies, where he currently serves as managing director.

Daniel McFadden appointed as Chief Operating Officer. Toby Scott Barnhart resigned as director.

✦AdaptHealth Corp. appointed Daniel McFadden as Chief Operating Officer while director Toby Scott Barnhart resigned, signaling potential management restructuring that investors should monitor for strategic implications.

👤 Daniel McFadden — I'll search for information about Daniel McFadden's appointment at AdaptHealth Corp. and his career history. Daniel McFadden has more than 30 years of international business experience in general management, continuous improvement, operations, supply chain, and engineering leadership roles across several industries. Prior to joining AdaptHealth, he served as SVP Business Systems at Regal Rexnord, Vice President Operations and Supply Chain at Beckman Coulter Life Sciences and Danaher Corporation, and Vice President Manufacturing, Distribution, and Logistics at Videojet. He spent a significant portion of his early career at the Timken Company with increasing responsibility in R&D, operations, supply chain, and general management.

Michael A. Lampman resigned as director. effective September 30, 2026.

✦Energizer Holdings loses director Michael A. Lampman effective September 30, 2026, requiring the board to fill the vacancy and potentially affecting governance oversight and strategic direction.

Acquired W3C Corp for $76,273,333.30.

✦Exodus Movement acquired W3C Corp for approximately $76.3 million, expanding its portfolio and potentially increasing shareholder equity value through this strategic business combination.

Merger by Corebridge, Equitable, Mountain Holding. Cash: $1.00.

✦Corebridge Financial and Equitable Holdings are merging with Mountain Holding in an all-cash transaction valued at $1.00 per share, consolidating these insurance and financial services companies.

Tender offer for OF THE SECURITIES EXCHANGE ACT OF 1934 North Haven Private Income Fund LLC.

✦North Haven Private Income Fund LLC is conducting a tender offer to repurchase its own securities, providing shareholders an exit opportunity while potentially reducing outstanding shares.

Departure of Michelle Hook as Chief Financial Officer On April 30, 2026, Michelle Hook informed the Chief Executive Officer and General Counsel and Secretary of Portillo s Inc. The Board has initiated a process to identify her successor and has engaged a leading global executive search firm to assist in the search process.

✦Portillo's CFO Michelle Hook is departing effective April 30, 2026, with the board conducting a search for her replacement, creating near-term leadership uncertainty for the restaurant operator.

Timothy Terry appointed as Chief Business. Moishe Gubin appointed as Chief Business. Mr. Gubin appointed as Chief Business. Braden R. Smith appointed as Chief Business.

✦OptimumBank Holdings appointed three executives—Timothy Terry, Moishe Gubin, and Braden R. Smith—to Chief Business Officer roles, signaling organizational restructuring that investors should monitor for strategic direction clarity.

👤 Timothy Terry — Braden R. Smith, age 52, served as Chief Business Development Officer of Amerant Bank from November 2024 through April 2026, and held the position of Executive Vice President at Wintrust Financial Corporation from September 2009 to November 2024. He was appointed as President of OptimumBank effective May 1, 2026.

Departure of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. The information set forth in the Introductory Note and

✦Terns Pharmaceuticals experienced executive leadership changes with departures and new officer appointments, though the filing summary lacks specific details about compensation arrangements or director election outcomes.

Sungjoon Chae appointed as officer.

✦Apimeds Pharmaceuticals appointed Sungjoon Chae as an officer, signaling potential leadership changes that could influence the company's strategic direction and operational management.

👤 Sungjoon Chae — Sungjoon Chae is an architect and urban designer with extensive experience in large-scale real estate development and urban regeneration, with a background in planning and executing complex, mixed-use urban-scale developments. He has worked with notable architecture firms including Steven Holl Architects, Weiss/Manfredi, and Michael Maltzan Architecture on significant projects such as the 'Meander' apartment building in Helsinki and the U.S. Embassy master plan in New Delhi. Prior to his appointment at Apimeds, Chae served as CEO of Grundot and is the co-founder of Grün Dot, a company focused on sustainable urbanism and architecture.

of this Current Report on Form 8-K is hereby incorporated by reference into the registration statement on Form S-3 (File No.

✦Dorian LPG Ltd. announced an executive change, though specific personnel details and implications for the shipping company's leadership structure remain unclear from this filing excerpt.

Andrew Scribner resigned as principal accounting officer. effective May 22, 2026.

✦Kimberly-Clark's principal accounting officer Andrew Scribner is departing effective May 22, 2026, requiring the company to identify a replacement for this key financial reporting role.

The information set forth in the Introductory Note and

✦I'd be happy to help, but the summary appears incomplete. Could you please provide the full summary of the executive change at Farmer Bros. Co. (FARM)? This will allow me to write an accurate one-sentence analysis for investors.

Grant Thornton appointed as new auditor.

✦Workiva replaced its auditor with Grant Thornton, which could signal accounting concerns or reflect routine auditor rotation requiring investor scrutiny of any disclosed disagreements.

On May 2, 2026, Axos Bank (the Bank ), a subsidiary of Axos Financial, Inc. The Bank acquired approximately $2.3 billion of deposits from Jenius Bank and received cash, less a negotiated premium.

✦Axos Financial acquired $2.3 billion in deposits from Jenius Bank, expanding its deposit base and strengthening its balance sheet through this strategic transaction.

Acquired Cullgen Inc.

✦Gyre Therapeutics completed its acquisition of Cullgen Inc., expanding its therapeutic pipeline and potentially strengthening its competitive position in the biotech market.

👤 Ying Luo — I'll search for information about Ying Luo's career history. Based on the search results, I cannot find information confirming that Ying Luo was appointed as Chief Executive Officer at Gyre Therapeutics. In fact, the most recent information from January 2025 indicates that Ying Luo resigned as Chairman and a member of the Board of Directors of Gyre , with Han Ying, Ph.D. serving as CEO. However, I can provide information about his actual career history: Dr. Luo is the founder of GNI Group Ltd. (founded in 2005) serving as Executive President and CEO, and founder of Cullgen, Inc. (founded in 2018) serving as Chairman, President & Chief Executive Officer. Under his leadership at GNI Group, he achieved the first Class 1 drug approval from China FDA in treating IPF in 2011 and built a nationwide orphan drug sales network in China.

20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 Genco Shipping Trading Limited (Name of Subject Company (Issuer)) 4 Dragon Merger Sub Inc. (Offeror) a direct wholly-owned subsidiary of Diana Shipping Inc.

✦Diana Shipping's subsidiary launched a tender offer for Genco Shipping & Trading, representing a potential merger that would combine two major shipping companies if shareholders accept the acquisition proposal.

Davin D. Lee appointed as Class III director. effective April 30, 2026.

✦Navitas Semiconductor appoints Davin D. Lee as Class III director effective April 30, 2026, expanding board composition ahead of the annual shareholder meeting cycle.

👤 Davin D. Lee — Davin D. Lee brings over 30 years of semiconductor and power management experience, most recently serving as Senior Vice President and General Manager at Renesas Corporation, with prior leadership roles at Dialog Semiconductor, Intersil, Altera, and National Semiconductor. His experience is defined by successfully transforming business units to capture new growth and profitability.

Entered into Amended and Restated Agreement and Plan of Merger with Garda Therapeutics, Inc.

✦Assertio Holdings agreed to merge with Garda Therapeutics under an amended merger agreement, potentially consolidating the two pharmaceutical companies and reshaping Assertio's corporate structure.

Paul Keel appointed as independent director.

✦Cooper Companies appointed Paul Keel as an independent director, strengthening board governance and oversight of the medical device company's operations.

👤 Paul Keel — Paul Keel has served as President and Chief Executive Officer of Envista Holdings Corporation, a global specialty medical technology company, since 2024. Prior to joining Envista, Keel served as CEO of Smiths Group plc, a diversified global industrial technology company and FTSE constituent, from 2021 to 2024. He brings extensive experience from 16 years at 3M, where he held various leadership positions, including Group President of the Consumer Business Group and President of 3M Medical.

Julia Brau Donnelly appointed as principal accounting officer. effective May 8, 2026.

✦Pinterest appointed Julia Brau Donnelly as principal accounting officer effective May 8, 2026, strengthening its financial reporting leadership.

👤 Julia Brau Donnelly — I'll search for information about Julia Brau Donnelly's career history. Julia Brau Donnelly was Vice President and Global Head of Finance & Accounting at Wayfair, where she held several positions of increasing responsibility over more than seven years. Prior to Wayfair, she was a private equity investor in media and technology companies at Thomas H. Lee Partners. She holds a Bachelor of Arts in Economics from Stanford University and an MBA from Harvard Business School.

Paul E. Davis appointed as director. Paul E. Davis resigned as chief executive officer.

✦Adeia Inc. (ADEA) appointed Paul E. Davis as director while he resigned as CEO, signaling a leadership transition that may indicate strategic restructuring or internal management changes.

👤 Paul E. Davis — Paul E. Davis worked as an attorney at Skadden, Arps, Slate, Meagher & Flom LLP, focusing on mergers and acquisitions, corporate securities matters and corporate governance , before joining Tessera Technologies in 2011 and being promoted to Senior Vice President, General Counsel and Corporate Secretary in 2013 . He guided the company through several transformative transactions, including mergers with DTS in 2016 and TiVo in 2020 , and served as Chief Legal Officer and President of the IP Licensing business of Xperi Holding Corporation before becoming CEO of Adeia in 2022 .

Newsom currently serves and will continue to serve as Executive Vice President of the Company and President of Community Trust Bank, Inc., the Company s wholly owned bank subsidiary, until his planned retirement on February 5, 2027.

✦Community Trust Bancorp's President and Executive Vice President will retire in February 2027, providing investors with over a year to assess the company's succession planning and leadership transition readiness.

Effective as of April 28, 2026, Richard Akright advised the Company that he was resigning from his position as Co-Chief Financial Officer of urban-gro, Inc. Akright s resignation was not due to any disagreement with the Company on any matter relating to the Company s operations, policies or practices, including accounting principles, practices and disclosures.

✦Urban-gro's Co-Chief Financial Officer Richard Akright resigned effective April 28, 2026, with no disagreement cited, potentially signaling potential CFO restructuring or leadership transitions ahead.

Laura C. Holson appointed as Chief Operating Officer. effective May 29, 2026.

✦New Mountain Finance Corporation appointed Laura C. Holson as Chief Operating Officer effective May 29, 2026, potentially strengthening operational management at the BDC.

👤 Laura C. Holson — Laura C. Holson, age 40, has been with New Mountain Capital since 2009, where she currently serves as a Managing Director focused on the credit business and has held the position of Chief Operating Officer of New Mountain Capital's credit platform since January 2022. She previously held various roles at New Mountain Capital including Head of Capital Markets and has been a member of its credit team for over 13 years. Ms. Holson has served as Chief Operating Officer of the Company since February 2022 and previously served as interim Chief Financial Officer and Treasurer from March 2023 to November 2023.

Irving Minnaker resigned as director.

✦Cycurion Inc. experienced a directorate change as Irving Minnaker resigned, potentially signaling internal governance shifts that investors should monitor for impact on board composition and strategic direction.

Appointment of Chief Medical Officer On May 4, 2026, Pasithea Therapeutics Corp. as Chief Medical Officer of the Company, effective May 1, 2026.

✦Pasithea Therapeutics appointed a new Chief Medical Officer effective May 1, 2026, strengthening its clinical leadership as the biotech company advances its therapeutic development pipeline.

Bret DiMarco resigned as Senior Vice President.

✦Agilent Technologies (A) experienced a senior management departure with Bret DiMarco's resignation as Senior Vice President, which may signal organizational changes but lacks detail on reasons or succession plans.

(the Company or Lisata ) and Kuva Labs Inc., a Delaware corporation ( Parent ), together with Kuva Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ( Purchaser ), entered into an amendment and waiver (the Amendment and Waiver ) to the previously announced Agreement and Plan of Merger, dated as of March 6, 2026, by and among Parent, Purchaser and the Company (the Merger Agreement ). Under the Amendment and Waiver, Parent has also agreed to pay certain expenses of

✦Lisata Therapeutics amended its merger agreement with Kuva Labs, with Kuva agreeing to cover additional company expenses, modifying terms of the previously announced acquisition deal.

Entered into Agreement and Plan of Merger with Global Net Lease, Inc.

✦Modiv Inc. agreed to merge with Global Net Lease, Inc., combining the two net lease REITs in a significant consolidation that will create a larger real estate investment entity.

Entered into Confidential Settlement and Mutual Release Agreement with Inscobee Inc.

✦Apimeds Pharmaceuticals (APUS) settled disputes with Inscobee Inc. under confidential terms, resolving mutual claims through a release agreement that eliminates legal liabilities for both parties.

Michal Fisher appointed as director. Gumulka resigned as Director.

✦CNS Pharmaceuticals appointed Michal Fisher as director while Gumulka resigned, signaling potential strategic shifts in the company's board governance and leadership direction.

👤 Michal Fisher — Michal Fisher is a senior life sciences executive with over 15 years of experience in business development, corporate strategy, investor relations, and deal structuring across biotech, pharma, and medtech sectors. She currently serves as Chief Business Officer at BioGenCell and previously held the position of Head of Corporate Development at LifeSci Partners (2020-2025), where she supported the growth of multiple life sciences advisory and investment platforms. Earlier in her career, she held leadership roles in business development and licensing at Neopharm and strategic alliances at SK Pharma, and holds a B.Sc. in Biotechnology and M.A. in Law from Bar-Ilan University.

The following summary is qualified in its entirety by the provisions of the CIC Agreement. (For these purposes, the terms cause, good reason and change in control are each defined in the CIC Agreement.) In addition, the Company will pay or reimburse the executive for the cost of the premiums charged to continue health coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act and life insurance coverage for the executive and his eligible dependents, for a period of up to eighteen mo

✦Imunon's executive departure triggers change-in-control severance benefits including health and life insurance continuation for up to eighteen months, indicating potential leadership transition or company restructuring.

Amendment and Restatement of The Williams Companies, Inc. The Company s Board of Directors approved the Amendment to the Incentive Plan on January 27, 2026, subject to stockholder approval, and the Amendment to the Incentive Plan became effective with such stockholder approval on April 28, 2026.

✦Williams Companies received stockholder approval to amend its incentive plan on April 28, 2026, expanding equity compensation flexibility for executive retention and performance incentives.

Acquisition for $1,027,798.

✦Tiptree Inc. completed an acquisition for approximately $1.0 million, a relatively small add-on deal that expands the company's portfolio without material financial impact.

Zachary C. Lauer appointed as Senior Vice President.

✦Trex Company appointed Zachary C. Lauer as Senior Vice President, strengthening its executive leadership team in the composite decking and railing materials sector.

👤 Zachary C. Lauer — I'll search for information about Zachary C. Lauer and his career history. Zachary C. Lauer brings more than two decades of operations and manufacturing leadership experience, including ten years with Trex and prior senior roles at Newell-Rubbermaid and Federal-Mogul . Before his current appointment, he served as Senior Vice President of Supply Chain and Manufacturing, and previously held roles including Group Vice President of Supply Chain . He holds an MBA from Villanova University and a BS in Aerospace Engineering from the United States Military Academy .

The information set forth in the Introductory Note of this Current Report on Form 8-K is incorporated by reference into this

✦United Homes Group completed an acquisition, though the specific target company and financial terms are not detailed in the provided summary excerpt.

encement of proposed sale of the securities to the public: As soon as practicable after the effective date of this registration statement and the satisfaction or waiver of all other conditions to the proposed merger described in the enclosed prospectus and proxy statement. If the securities being registered on this form are being offered in connection with the formation of a holding company and there is compliance with General Instruction G, check the following box: ☐ If this form is file

✦Independent Bank Corporation's proposed merger with Independent Bank Corp (INDB) will proceed through a public securities offering pending regulatory approval and satisfaction of merger conditions.

Charles H. Protell appointed as director. Charles Protell appointed as managing director. Atish Shah will not stand for re-election. effective April 27, 2026.

✦Dave & Buster's (PLAY) appointed Charles Protell as managing director while director Atish Shah stepped down, signaling potential strategic shifts in leadership and governance effective April 2026.

👤 Charles H. Protell — Charles H. Protell is currently President and Chief Financial Officer of Golden Entertainment, Inc., where he has served since November 2016, being promoted to President in August 2019. Prior to Golden, he was a managing director at Macquarie Capital's investment banking group and co-founder and managing director at REGAL Capital Advisors, and held various investment banking roles at Credit Suisse, Deutsche Bank, and CIBC World Markets. He holds a Bachelor of Science degree in Commerce from the University of Virginia.

Acquired Zayo Group Holdings, Inc.

✦Crown Castle completed its acquisition of Zayo Group Holdings, expanding its infrastructure portfolio and strengthening its position in fiber and data center assets.

Michael A. Regan appointed as director. Michael H. Rogers resigned as director. effective June 1, 2026.

✦Universal Logistics Holdings replaced director Michael H. Rogers with Michael A. Regan effective June 1, 2026, signaling a board composition shift that investors should monitor for strategic implications.

👤 Michael A. Regan — I'll search for information about Michael A. Regan's career history. The search results show information about Michael S. Regan (the EPA administrator) and Michael A. Regan (the logistics executive). Based on the search results, I have information about Michael A. Regan: Michael A. Regan is the Chief Relationship Development Officer of TranzAct Technologies, Inc., a privately held logistics information company that he co-founded in 1984, after serving as CEO and Chairman until 2011. Prior to starting TranzAct, he worked for Bank of America, PriceWaterhouse, and the Union Pacific Corporation. He serves on the boards of numerous industry groups including the American Society of Transportation & Logistics, National Industrial Transportation League and the National Association of Small Shippers, and is the past Chairman of the Transportation Intermediaries Association Foundation.

Tender offer for StepStone Private Credit Fund LLC.

✦StepStone Private Credit Fund is offering shareholders the opportunity to tender their shares back to the fund, likely providing liquidity for investors in this previously illiquid investment vehicle.

of this Current Report on Form 8-K, Carter s, Inc. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

✦Carter's, Inc. announced an executive leadership change, though specific details require reviewing the attached press release to assess potential impacts on company strategy and operational direction.